Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours.
Zhang J, Liu R, Gao S, Li W, Chen Y, Meng Y, Liu C, Jin W, Wu J, Wang Y, Hao Y, Yi S, Qing Y, Ge J, Hu X.
Zhang J, et al.
NPJ Breast Cancer. 2023 Apr 18;9(1):28. doi: 10.1038/s41523-023-00522-5.
NPJ Breast Cancer. 2023.
PMID: 37072437
Free PMC article.